Newsroom

Press Releases

See All

09/30/2026

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/30/2026

Sarepta Therapeutics Presents New Data at 2026 World Muscle Society Annual Congress Demonstrating Safety and Clinically Meaningful Functional Benefit of ELEVIDYS (delandistrogene moxeparvovec) in Older Ambulatory Patients with Duchenne
09/25/2026

Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress

Stories & Perspectives

Patient Voices

A decade in Duchenne: Stories from the community
Advocates & Innovators

How personal experience shapes support for Duchenne families
Inside the Science

Time to Rise From Floor: What it can tell us about when to act in Duchenne
Inside the Science

$muscle_fat_frac$

Muscle MRI in Duchenne: What it shows and why it matters
Patient Voices

A life in motion: One family’s journey with Duchenne
Patient Voices

When timing matters: Micah's Duchenne story
Inside the Science

From A to Dystrophin: The ABCDs of Duchenne
Inside the Science

Gene Therapy FAQs: What it is, how it works and what to expect
Advocates & Innovators

A trusted role in Duchenne care: Meet our Duchenne Nurse Educators
Patient Voices

A portrait of life with Duchenne: The Kasner family's story
Advocates & Innovators

Leading with science, grounded in patient impact: Meet James Richardson, M.D.
Patient Voices

Video: Scholarship Recipients, and Twins, Austin and Connor Travel Route 79 Together
Advocates & Innovators

Roots of innovation: From science fairs to the leading edge of precision genetic medicine
Advocates & Innovators

Navy veteran, lifelong learner, dedicated Duchenne Nurse Educator: Meet John Crane
Patient Voices

Wearable devices and the future of rare disease clinical trials: Landry’s story
Advocates & Innovators

Awards & Recognitions: Sarepta recognized for innovation and industry leadership
Patient Voices

When time is muscle: One dad shares his story to advocate for Duchenne newborn screening
Advocates & Innovators

Guardians of the last mile: Ensuring smooth delivery and a seamless patient experience
Inside the Science

What’s in a dose? Gene therapy dosing explained (Video)
Advocates & Innovators

A passion for patients, an influential mentor and a change in plans: Meet Danielle Griffin
Patient Voices

Creating pathways to LGMD genetic diagnosis: Spotlight on LGMD Grant Award recipient
Advocates & Innovators

Dragging tomorrow into today: Meet Rachael Potter, Ph.D.
Inside the Science

Understanding external controls and their importance to clinical trials for rare diseases
Culture & Community

What’d you do this summer? Our summer interns share lessons learned
Advocates & Innovators

A conversation with CFO Ian Estepan, recipient of the 2022 CFO of the Year award from the Boston Business Journal
Inside the Science

Seroprevalence: What patients should know about pre-existing antibodies to gene therapy
Inside the Science

Patient registries: A catalyst for developing new therapies for rare diseases
Inside the Science

Measurements used in clinical trials for Duchenne muscular dystrophy – an overview
Advocates & Innovators

Expanding access to newborn screening for those with rare diseases
Patient Voices

Advocacy community unites to support families
Culture & Community

How Sarepta infused its corporate brand with urgency and optimism on behalf of patients

Media Library

Sarepta Corporate Logos, Images & Fact Sheets

Press Contact

Tracy Sorrentino
Vice President, Corporate Affairs
Sarepta Therapeutics, Inc.
[email protected]
617-274-4052